期刊文献+

Castleman病临床和病理分析 被引量:4

Clinical and pathological study on Castleman disease
下载PDF
导出
摘要 目的:了解Castleman病临床特点及组织病理学改变,提高对该病的认识。方法:回顾性分析16例Castleman病的临床特点、组织病理学改变及临床诊断治疗。结果:16例患者男性居多,中位年龄42岁,以多中心型多见,表现为多处淋巴结肿大,单一部位病变即局灶型相对少见。系统性症状多见于多中心型,有肾脏、肝脏及周围神经累及。淋巴结病理以透明血管型多见,浆细胞型及混合型次之。结论:Castleman病具有典型的淋巴结组织病理学改变,但临床表现无特征性,易与淋巴瘤等病变相混淆,局灶型手术切除预后较好,多中心型预后则与起病时系统累及情况有关。 Objective:To understand the clinical features and histopathology of Castleman disease(CD)so as to better recognize the disease.Method:The clinical features,histopathology,diagnosis and therapy of sixteen patients with CD were retrieved and analyzed.Result:Sixteen patients were male-dominated,with a median age of 42 years old.Multicentric Castleman's disease(MCD)was the majority,which showed widespread lymphadenopathy.Solitary lymphadenopathy that is unicentric Castleman's disease(UCD)was relatively uncommon.Systemic symptoms were more common in MCD,accompaned with kidney,liver and peripheral nerve injured.Pathologically,hyaline vascular type was the majority,plasma cell type and mixed type followed by.Conclusion:The lymph nodes of CD show typical histopathological features.Since there is no characteristic clinical manifestation,it tends to be misdiagnosed as lymphoma.UCD is curable by surgical resection of tumor.The prognosis of patients with MCD was associated with systemic damage when the disease was diagnosed.
出处 《临床血液学杂志》 CAS 2010年第4期401-403,共3页 Journal of Clinical Hematology
关键词 CASTLEMAN病 血管滤泡性淋巴结增生 临床 组织病理 Castleman's disease angiofollicular lymph node hyperplasia clinical histopathology
  • 相关文献

参考文献15

  • 1CASTLEMAN B,IVERSON L,MENENDEZ V P.Localized mediastinal lymph-node hyperplasia resembling thymoma[J].Cancer,1956,9:822-830.
  • 2PAREZ N,BADER-MEUNIER B,ROY C C,et al.Paediatric Castleman disease:report of seven cases and review of the literature[J].Eur J Pediar,1999,158:631-637.
  • 3BOWNE W B,LEWIS J J,FILIPPA D A,et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature[J].Cancer,1999,85:706-717.
  • 4SOULIER J,GROLLET L,OKSENHENDLER E,et al.Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease[J].Blood,1995,86:1276-1280.
  • 5NISHIMOTO N,KANAKURA Y,AOZASA K,et al.Humanized anti-interleukin-6 receptor antibody treatment of multicentric castleman disease[J].Blood,2005,106:2627-2632.
  • 6FLENDRIG J A.Benign giant lymphoma:clinicopathologic correlation study[M] //The year book of cancer.Chicago:Year Book Medical Publishers,1970:296-299.
  • 7KELLER A R,HOCHHOLZER L,CASTLEMAN B,et al.Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations[J].Cancer,1972,29:670-683.
  • 8HERRADA J,CABANILLAS F,RICE L,et al.The clinical behavior of localized and multicentric Castleman disease[J].Ann Intern Med,1998,128:657-662.
  • 9JACOBS A S,VIDNOVIC N,PATEL H,et al.Durable remission of HIV-negative,Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate[J].Clin Rheumatol,2007,26:1148-1150.
  • 10REVUELTA M P,NORD J A.Successful treatment of multicentric Castleman's disease in a patient with human immunodeficiency virus infection[J].Clin Infect Dis,1998,26:527-527.

同被引文献15

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部